Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (549)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
132
2024
2929
9.780
Why?
Drug Resistance, Neoplasm
25
2020
308
3.280
Why?
Gene Expression Regulation, Neoplastic
51
2022
828
3.190
Why?
Gene Expression Profiling
43
2023
1032
2.860
Why?
Cell Proliferation
25
2022
1007
2.270
Why?
Antineoplastic Agents
29
2020
1171
2.180
Why?
Plasma Cells
22
2024
223
2.030
Why?
Cell Line, Tumor
44
2024
1403
1.930
Why?
Monoclonal Gammopathy of Undetermined Significance
7
2023
103
1.740
Why?
Neoplastic Stem Cells
7
2020
103
1.710
Why?
Pyrazines
19
2023
187
1.620
Why?
Paraproteinemias
9
2024
72
1.480
Why?
Lymphoma, B-Cell
5
2021
63
1.450
Why?
Mice
45
2024
5739
1.420
Why?
Boronic Acids
17
2014
182
1.400
Why?
Apoptosis
17
2022
1101
1.400
Why?
Bone Resorption
6
2024
304
1.390
Why?
Humans
151
2024
49974
1.300
Why?
Neoplasm Proteins
7
2021
322
1.220
Why?
Prognosis
36
2024
1942
1.170
Why?
Osteolysis
4
2022
75
1.150
Why?
Animals
54
2024
13187
1.140
Why?
B-Lymphocytes
8
2021
170
1.120
Why?
Cell Cycle Proteins
4
2023
166
1.060
Why?
T-Lymphocytes
8
2024
338
1.020
Why?
Hematopoietic Stem Cell Transplantation
6
2024
565
1.010
Why?
Ubiquitination
3
2021
43
0.970
Why?
Proteasome Inhibitors
7
2020
104
0.950
Why?
Signal Transduction
21
2023
1618
0.900
Why?
Proteasome Endopeptidase Complex
4
2018
114
0.850
Why?
MicroRNAs
7
2022
353
0.850
Why?
Antigens, CD
8
2024
219
0.780
Why?
Carrier Proteins
3
2017
304
0.690
Why?
CDC2-CDC28 Kinases
3
2015
12
0.680
Why?
Cation Transport Proteins
2
2019
27
0.670
Why?
Ubiquitins
2
2016
39
0.650
Why?
Up-Regulation
6
2020
452
0.650
Why?
Disease Progression
17
2023
825
0.640
Why?
Cyclin-Dependent Kinases
2
2010
28
0.640
Why?
Glycolysis
3
2022
70
0.640
Why?
Mice, Inbred NOD
5
2020
96
0.640
Why?
Oligonucleotide Array Sequence Analysis
19
2014
411
0.630
Why?
Waldenstrom Macroglobulinemia
1
2018
40
0.630
Why?
Proto-Oncogene Proteins c-akt
5
2023
157
0.610
Why?
Chromosome Aberrations
6
2023
297
0.610
Why?
Cell Differentiation
9
2023
651
0.600
Why?
Iron
2
2017
122
0.600
Why?
Pyrimidines
3
2015
192
0.590
Why?
STAT3 Transcription Factor
4
2016
81
0.590
Why?
Cell Survival
10
2020
600
0.580
Why?
Pyruvate Kinase
1
2017
7
0.580
Why?
Ascorbic Acid
1
2017
24
0.580
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
989
0.560
Why?
RNA Splicing
1
2017
37
0.560
Why?
Protein-Tyrosine Kinases
2
2015
95
0.530
Why?
Down-Regulation
9
2019
348
0.520
Why?
Cyclopentanes
1
2015
10
0.520
Why?
Transplantation, Autologous
5
2024
466
0.510
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
67
0.510
Why?
Thalidomide
10
2023
377
0.500
Why?
Aldehyde Dehydrogenase
1
2014
26
0.500
Why?
Osteoclasts
7
2023
425
0.490
Why?
Dexamethasone
7
2024
430
0.480
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
18
0.480
Why?
Hematologic Neoplasms
1
2015
99
0.450
Why?
Receptors, Retinoic Acid
2
2013
23
0.450
Why?
Models, Biological
5
2018
727
0.450
Why?
Cystatin M
2
2024
20
0.450
Why?
RNA, Messenger
13
2021
1105
0.440
Why?
Tumor Microenvironment
5
2024
212
0.440
Why?
B-Cell Maturation Antigen
2
2024
90
0.430
Why?
Flow Cytometry
8
2018
476
0.430
Why?
Antigens, Neoplasm
6
2014
151
0.420
Why?
Glucuronidase
4
2018
46
0.420
Why?
Female
43
2024
26472
0.410
Why?
Antibodies, Bispecific
2
2023
60
0.400
Why?
Predictive Value of Tests
5
2016
903
0.400
Why?
Male
33
2024
25241
0.390
Why?
Mice, Transgenic
6
2021
555
0.380
Why?
Syndecan-1
6
2017
72
0.380
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.380
Why?
Arsenicals
1
2010
14
0.380
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.380
Why?
Oxides
1
2010
18
0.370
Why?
Janus Kinase 1
1
2010
17
0.360
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
595
0.360
Why?
Proto-Oncogene Proteins c-jun
2
2009
75
0.360
Why?
MAP Kinase Kinase 1
1
2010
23
0.360
Why?
Immunotherapy, Adoptive
2
2024
156
0.360
Why?
Killer Cells, Natural
4
2015
95
0.350
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.350
Why?
DNA-Binding Proteins
4
2021
427
0.350
Why?
Early Growth Response Protein 1
1
2009
35
0.340
Why?
Transcription Factors
6
2022
561
0.330
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
105
0.330
Why?
Oligopeptides
3
2015
89
0.330
Why?
Tretinoin
1
2009
53
0.330
Why?
Xenograft Model Antitumor Assays
7
2019
211
0.320
Why?
Osteogenesis
5
2023
352
0.310
Why?
NF-kappa B
3
2018
314
0.310
Why?
Genes, Neoplasm
1
2008
30
0.310
Why?
Tumor Cells, Cultured
6
2020
465
0.310
Why?
Antibodies
3
2024
154
0.310
Why?
Aged
24
2024
9310
0.310
Why?
Microarray Analysis
3
2018
73
0.300
Why?
Chromosomes, Human, Pair 1
4
2023
93
0.290
Why?
Immunologic Factors
5
2015
114
0.290
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.290
Why?
Tumor Suppressor Protein p53
2
2008
202
0.290
Why?
Interleukin-6
3
2019
264
0.290
Why?
Neoplasms
2
2015
1235
0.290
Why?
Neoplasms, Plasma Cell
2
2023
37
0.290
Why?
Pyrazoles
2
2020
113
0.280
Why?
Small Molecule Libraries
2
2019
68
0.280
Why?
Mice, SCID
9
2018
175
0.270
Why?
Risk Factors
11
2018
3613
0.260
Why?
Middle Aged
23
2024
12069
0.250
Why?
Genomics
2
2023
286
0.250
Why?
Survival Rate
8
2020
894
0.250
Why?
Enzyme Inhibitors
4
2019
391
0.240
Why?
Polycomb Repressive Complex 2
2
2021
47
0.240
Why?
Bone Diseases
4
2016
99
0.240
Why?
Bone Marrow
7
2024
362
0.240
Why?
Receptors, LDL
1
2024
66
0.230
Why?
Ferritins
1
2024
30
0.230
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.230
Why?
Propionates
1
2024
24
0.230
Why?
Hydroxybenzoates
1
2024
25
0.230
Why?
Myeloid Progenitor Cells
1
2023
18
0.230
Why?
X-Ray Microtomography
1
2024
77
0.230
Why?
Histocompatibility Antigens Class I
2
2015
44
0.230
Why?
Antigens, CD19
3
2018
24
0.230
Why?
Cholesterol
1
2024
146
0.230
Why?
Melphalan
3
2023
174
0.230
Why?
Bone Marrow Cells
4
2015
191
0.230
Why?
Neoplasms, Second Primary
1
2024
78
0.230
Why?
Membrane Glycoproteins
6
2009
240
0.220
Why?
Genes, myc
3
2019
40
0.220
Why?
Intercellular Signaling Peptides and Proteins
4
2007
104
0.220
Why?
Lymphoma
1
2024
66
0.220
Why?
Bone Diseases, Metabolic
1
2024
74
0.220
Why?
Homeostasis
1
2024
200
0.220
Why?
Cluster Analysis
5
2009
235
0.220
Why?
Gene Knockdown Techniques
3
2018
106
0.220
Why?
Bone and Bones
2
2021
469
0.220
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.210
Why?
Recurrence
7
2018
652
0.210
Why?
Protein Binding
2
2018
660
0.210
Why?
Neutropenia
1
2023
116
0.210
Why?
Randomized Controlled Trials as Topic
6
2016
549
0.210
Why?
Periodontitis
1
2022
10
0.210
Why?
Phenols
1
2024
113
0.210
Why?
Case-Control Studies
8
2020
1131
0.210
Why?
Reactive Oxygen Species
4
2017
408
0.210
Why?
Antibodies, Monoclonal
3
2013
459
0.210
Why?
In Situ Hybridization, Fluorescence
5
2023
259
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.200
Why?
Protein Stability
2
2020
43
0.200
Why?
Osteoporosis
1
2023
146
0.200
Why?
Adult
20
2024
13236
0.200
Why?
Kaplan-Meier Estimate
5
2016
466
0.200
Why?
Arthritis, Rheumatoid
1
2022
105
0.200
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.190
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.190
Why?
Ubiquitin-Protein Ligases
2
2020
92
0.190
Why?
RANK Ligand
1
2022
179
0.190
Why?
Venous Thromboembolism
3
2011
68
0.190
Why?
Oxidative Stress
4
2016
770
0.190
Why?
Phenylpropionates
1
2021
13
0.190
Why?
Hippurates
1
2021
11
0.190
Why?
Gene Expression
4
2017
609
0.190
Why?
Proteolysis
3
2017
94
0.190
Why?
Cell Cycle
4
2010
231
0.190
Why?
Bone Neoplasms
2
2015
179
0.190
Why?
Membrane Proteins
3
2017
341
0.190
Why?
Colorectal Neoplasms
2
2022
236
0.190
Why?
Colonic Neoplasms
1
2022
161
0.190
Why?
Adaptor Proteins, Signal Transducing
1
2021
197
0.190
Why?
Protease Inhibitors
3
2011
58
0.180
Why?
Treatment Outcome
12
2020
5141
0.180
Why?
Cell Movement
2
2015
247
0.180
Why?
Receptors, G-Protein-Coupled
1
2021
53
0.180
Why?
Antigens, CD20
2
2014
6
0.180
Why?
Neoplasm Metastasis
4
2015
231
0.180
Why?
Retrospective Studies
7
2024
6108
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
55
0.180
Why?
Time Factors
8
2021
2903
0.180
Why?
Disease-Free Survival
7
2016
454
0.180
Why?
Evolution, Molecular
1
2021
99
0.180
Why?
Chromosomal Instability
3
2021
16
0.180
Why?
Cytotoxicity, Immunologic
4
2015
54
0.180
Why?
Clinical Trials as Topic
1
2022
461
0.170
Why?
Tumor Suppressor Proteins
2
2019
128
0.170
Why?
Neoplasm Recurrence, Local
1
2024
614
0.170
Why?
DNA, Single-Stranded
1
2020
87
0.170
Why?
NF-E2-Related Factor 2
1
2019
41
0.170
Why?
Oncogene Proteins
1
2019
17
0.170
Why?
Mitosis
3
2015
91
0.170
Why?
Healthcare Disparities
1
2022
257
0.170
Why?
Carcinoma, Neuroendocrine
1
2019
24
0.160
Why?
Transplantation, Heterologous
2
2017
74
0.160
Why?
rab GTP-Binding Proteins
1
2019
35
0.160
Why?
Receptors, Interleukin-6
1
2018
22
0.160
Why?
Proto-Oncogene Proteins c-myc
2
2017
50
0.160
Why?
Drug Tolerance
1
2018
60
0.160
Why?
Pyridines
1
2019
130
0.160
Why?
Neovascularization, Pathologic
3
2009
161
0.160
Why?
Blotting, Western
3
2015
601
0.160
Why?
Lung Neoplasms
1
2024
606
0.150
Why?
Drug Therapy, Combination
2
2017
377
0.150
Why?
beta Catenin
2
2015
102
0.150
Why?
M Phase Cell Cycle Checkpoints
1
2017
4
0.150
Why?
Mice, Knockout
4
2023
841
0.150
Why?
Hydroxamic Acids
2
2014
38
0.150
Why?
Aerobiosis
1
2017
14
0.140
Why?
Microfilament Proteins
1
2017
43
0.140
Why?
Thyroid Hormones
1
2017
18
0.140
Why?
Onium Compounds
1
2016
13
0.140
Why?
Calcium-Binding Proteins
1
2017
54
0.140
Why?
Organophosphorus Compounds
1
2016
15
0.140
Why?
Deoxyglucose
1
2016
36
0.140
Why?
Histone Deacetylase Inhibitors
2
2014
53
0.140
Why?
Survival Analysis
6
2020
653
0.140
Why?
Inhibitor of Apoptosis Proteins
3
2015
20
0.140
Why?
Syndecans
3
2006
34
0.140
Why?
Gene Deletion
2
2008
266
0.140
Why?
Pancreatic Neoplasms
1
2019
208
0.140
Why?
Aged, 80 and over
7
2021
3129
0.140
Why?
RNA Interference
2
2015
179
0.140
Why?
Ribosomal Proteins
1
2016
25
0.130
Why?
Cell Death
1
2016
181
0.130
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
43
0.130
Why?
Proteoglycans
3
2006
80
0.130
Why?
Macrophages
2
2022
363
0.130
Why?
Proto-Oncogene Proteins
2
2009
149
0.130
Why?
Oncolytic Virotherapy
1
2015
16
0.130
Why?
Gene Dosage
2
2013
78
0.130
Why?
Cell Adhesion Molecules
1
2015
88
0.130
Why?
Polysaccharides
1
2015
50
0.130
Why?
Receptors, Transferrin
1
2015
16
0.130
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
44
0.130
Why?
Side-Population Cells
1
2015
3
0.130
Why?
Lentivirus
1
2015
16
0.130
Why?
Retinal Dehydrogenase
1
2014
10
0.130
Why?
Serine Endopeptidases
2
2006
52
0.130
Why?
Receptors, Cell Surface
1
2015
122
0.120
Why?
Adenine
1
2015
32
0.120
Why?
Caspase 3
2
2022
97
0.120
Why?
Serum
1
2014
32
0.120
Why?
Cell Lineage
1
2014
83
0.120
Why?
Proto-Oncogene Proteins c-kit
1
2014
36
0.120
Why?
Superoxide Dismutase
1
2014
113
0.120
Why?
Translocation, Genetic
4
2021
264
0.120
Why?
Tumor Burden
3
2020
132
0.120
Why?
Piperidines
1
2015
98
0.120
Why?
Cyclins
3
2015
38
0.120
Why?
HLA Antigens
1
2014
52
0.120
Why?
Alkaline Phosphatase
2
2011
94
0.120
Why?
Glycoproteins
1
2014
115
0.120
Why?
Repressor Proteins
4
2015
151
0.110
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.110
Why?
Leukemia, Plasma Cell
1
2013
33
0.110
Why?
Lactate Dehydrogenases
1
2013
1
0.110
Why?
Phenotype
4
2009
729
0.110
Why?
Genome, Human
2
2021
111
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
63
0.110
Why?
Follow-Up Studies
5
2024
2182
0.110
Why?
Scavenger Receptors, Class A
1
2013
39
0.110
Why?
bcl-X Protein
1
2013
50
0.110
Why?
Leukemia
1
2013
65
0.110
Why?
Dose-Response Relationship, Drug
4
2020
1376
0.110
Why?
Disease Models, Animal
4
2020
1455
0.110
Why?
Heat-Shock Proteins
1
2013
106
0.100
Why?
RNA, Neoplasm
3
2007
44
0.100
Why?
Clinical Trials, Phase III as Topic
2
2012
43
0.100
Why?
RNA, Small Interfering
2
2010
215
0.100
Why?
Forkhead Transcription Factors
2
2023
112
0.100
Why?
Cysteine Proteinase Inhibitors
1
2011
22
0.100
Why?
Drug Screening Assays, Antitumor
3
2020
136
0.100
Why?
Activated Protein C Resistance
1
2011
10
0.100
Why?
Factor V
1
2011
11
0.100
Why?
Protein Isoforms
2
2009
119
0.100
Why?
Glucocorticoids
1
2013
219
0.100
Why?
Acetylcysteine
1
2011
100
0.100
Why?
Interferon Regulatory Factor-1
1
2010
14
0.090
Why?
Cell Growth Processes
1
2010
22
0.090
Why?
HLA-A Antigens
2
2007
10
0.090
Why?
Alleles
2
2021
250
0.090
Why?
Gene Silencing
2
2007
119
0.090
Why?
Cells, Cultured
6
2015
1573
0.090
Why?
Epigenesis, Genetic
2
2023
374
0.090
Why?
Immunophenotyping
5
2010
109
0.090
Why?
Thrombosis
1
2012
248
0.090
Why?
K562 Cells
3
2016
42
0.090
Why?
Microtubule-Associated Proteins
1
2009
67
0.080
Why?
Bone Remodeling
1
2010
150
0.080
Why?
Recombinant Proteins
1
2010
486
0.080
Why?
Chromosome Mapping
2
2006
156
0.080
Why?
Thromboembolism
1
2009
54
0.080
Why?
Neoplasm Staging
3
2024
740
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Mutation
3
2021
1294
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
ras Proteins
2
2020
64
0.080
Why?
Neoplasm Transplantation
2
2020
85
0.080
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
7
0.080
Why?
Angiogenesis Inhibitors
1
2009
187
0.080
Why?
Patient Selection
1
2009
253
0.080
Why?
Genes, abl
1
2007
2
0.080
Why?
Protein Tyrosine Phosphatases
1
2007
24
0.080
Why?
Adoptive Transfer
1
2007
40
0.080
Why?
Breast Neoplasms
2
2007
1174
0.070
Why?
Gene Expression Regulation
2
2022
976
0.070
Why?
HEK293 Cells
2
2019
222
0.070
Why?
Cancer Vaccines
1
2007
78
0.070
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
72
0.070
Why?
Drug Evaluation, Preclinical
2
2021
144
0.070
Why?
Caspases
1
2007
104
0.070
Why?
Cyclin D
1
2006
18
0.070
Why?
Chromosome Banding
1
2006
24
0.070
Why?
Proportional Hazards Models
2
2024
402
0.070
Why?
Models, Genetic
1
2006
170
0.070
Why?
Palatine Tonsil
2
2003
11
0.070
Why?
Peptides
1
2007
223
0.070
Why?
DNA Damage
1
2008
301
0.070
Why?
Maf Transcription Factors, Large
1
2005
1
0.070
Why?
Gene Expression Regulation, Enzymologic
1
2007
181
0.070
Why?
Data Interpretation, Statistical
1
2006
158
0.060
Why?
Doxorubicin
2
2018
233
0.060
Why?
Protein Kinases
1
2005
71
0.060
Why?
Cyclin D1
1
2005
56
0.060
Why?
Antibody Formation
1
2005
54
0.060
Why?
Protein Biosynthesis
2
2003
253
0.060
Why?
Mice, Inbred C57BL
2
2021
1816
0.060
Why?
Cystadenocarcinoma, Serous
1
2004
70
0.060
Why?
Papillomaviridae
1
2005
102
0.060
Why?
Carcinoma, Papillary
1
2004
48
0.060
Why?
Base Sequence
3
2015
643
0.060
Why?
Transfection
2
2020
354
0.060
Why?
Transcription, Genetic
1
2005
369
0.060
Why?
Mice, Inbred BALB C
2
2019
304
0.060
Why?
Drug Synergism
2
2014
150
0.060
Why?
Jurkat Cells
2
2014
29
0.060
Why?
Zebrafish Proteins
1
2003
21
0.060
Why?
Extracellular Matrix Proteins
1
2004
69
0.060
Why?
Genetic Predisposition to Disease
1
2007
510
0.060
Why?
Adipogenesis
1
2024
51
0.060
Why?
Steroids
1
2024
57
0.060
Why?
Ovariectomy
1
2024
119
0.060
Why?
Sequence Analysis, RNA
1
2024
91
0.060
Why?
PPAR gamma
1
2024
73
0.060
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Oxidative Phosphorylation
1
2023
39
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
38
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
8
0.050
Why?
Cytogenetic Analysis
1
2023
82
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
31
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
75
0.050
Why?
Oncogene Proteins, Fusion
1
2002
58
0.050
Why?
Macrophage Activation
1
2022
25
0.050
Why?
Chromosome Deletion
1
2023
140
0.050
Why?
Porphyromonas gingivalis
1
2022
16
0.050
Why?
Computational Biology
2
2020
214
0.050
Why?
Geography
1
2022
61
0.050
Why?
Protein Kinase Inhibitors
2
2014
204
0.050
Why?
Chromatin
1
2023
151
0.050
Why?
Uterine Cervical Neoplasms
1
2005
277
0.050
Why?
Inflammasomes
1
2022
58
0.050
Why?
Diploidy
3
2007
26
0.050
Why?
DNA, Neoplasm
1
2002
147
0.050
Why?
Models, Animal
2
2015
233
0.050
Why?
Mutation Rate
1
2021
36
0.050
Why?
DNA Primers
2
2015
207
0.050
Why?
Clone Cells
1
2021
74
0.050
Why?
Proteins
1
2003
342
0.050
Why?
Genes, Tumor Suppressor
1
2021
73
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
HCT116 Cells
1
2020
22
0.050
Why?
DNA Copy Number Variations
1
2021
110
0.050
Why?
Ovarian Neoplasms
1
2004
447
0.050
Why?
Double-Blind Method
2
2014
681
0.040
Why?
Cytokines
3
2009
612
0.040
Why?
Wnt Signaling Pathway
1
2021
92
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Immunohistochemistry
3
2009
973
0.040
Why?
Gene Knockout Techniques
1
2019
40
0.040
Why?
Software
1
2002
273
0.040
Why?
Drug Discovery
1
2020
85
0.040
Why?
DNA
1
2023
541
0.040
Why?
Genetic Variation
1
2020
213
0.040
Why?
Crystallography, X-Ray
1
2019
147
0.040
Why?
Protein Phosphatase 2
1
2019
5
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
169
0.040
Why?
G1 Phase
1
2019
14
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
Protein Conformation
1
2019
166
0.040
Why?
Multivariate Analysis
1
2021
577
0.040
Why?
Mice, Nude
1
2019
252
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.040
Why?
Immunotherapy
1
2021
238
0.040
Why?
Structure-Activity Relationship
1
2020
395
0.040
Why?
Wnt Proteins
2
2013
100
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
77
0.040
Why?
Drug Resistance
1
2018
63
0.040
Why?
Phosphorylation
1
2020
535
0.040
Why?
DNA Methylation
1
2023
548
0.040
Why?
Autophagy
1
2020
169
0.040
Why?
Cross-Sectional Studies
1
2022
1557
0.040
Why?
Cell Cycle Checkpoints
1
2017
32
0.040
Why?
CD8-Positive T-Lymphocytes
2
2007
116
0.030
Why?
Cell Hypoxia
1
2016
82
0.030
Why?
Chronic Disease
1
2019
567
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
43
0.030
Why?
Biological Transport
1
2016
174
0.030
Why?
Models, Statistical
2
2008
224
0.030
Why?
Drug Interactions
1
2016
206
0.030
Why?
Mice, Inbred ICR
1
2016
22
0.030
Why?
Cell Line
2
2013
1000
0.030
Why?
Microscopy, Electron, Transmission
1
2015
75
0.030
Why?
Transcriptional Activation
1
2016
121
0.030
Why?
Vidarabine
1
2015
9
0.030
Why?
Mitoxantrone
1
2015
9
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Pharmacogenetics
2
2006
52
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
47
0.030
Why?
Vaccination
2
2007
266
0.030
Why?
China
1
2015
87
0.030
Why?
Vincristine
1
2015
89
0.030
Why?
Prednisone
1
2015
99
0.030
Why?
Ligands
1
2015
204
0.030
Why?
Molecular Targeted Therapy
1
2016
119
0.030
Why?
Disulfiram
1
2014
10
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Microscopy, Fluorescence
1
2015
162
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cyclophosphamide
1
2015
165
0.030
Why?
Risk Assessment
2
2009
1259
0.030
Why?
Glucose
1
2016
344
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
38
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
11
0.030
Why?
Chemotherapy, Adjuvant
1
2014
119
0.030
Why?
Lectins, C-Type
1
2013
30
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.030
Why?
Isoxazoles
1
2013
14
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
17
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
33
0.030
Why?
Glutathione
1
2014
295
0.030
Why?
Hedgehog Proteins
1
2013
33
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Itraconazole
1
2013
40
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, Glucocorticoid
1
2013
32
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Azacitidine
1
2013
34
0.030
Why?
Oxidants
1
2013
53
0.030
Why?
ADP-ribosyl Cyclase
2
2003
5
0.030
Why?
Epitopes
1
2013
59
0.030
Why?
Hydrocortisone
1
2013
107
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
96
0.030
Why?
MAP Kinase Signaling System
1
2013
119
0.030
Why?
Prospective Studies
2
2010
2364
0.030
Why?
Histone Deacetylases
1
2013
50
0.030
Why?
Hydrogen Peroxide
1
2013
115
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
129
0.030
Why?
Radiation, Ionizing
1
2013
100
0.030
Why?
Osteoblasts
2
2006
450
0.030
Why?
Transcriptome
1
2014
315
0.030
Why?
Clinical Trials, Phase II as Topic
1
2012
43
0.030
Why?
Viper Venoms
1
2011
7
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Risk
1
2011
320
0.020
Why?
Bone Density Conservation Agents
1
2010
77
0.020
Why?
Diphosphonates
1
2010
90
0.020
Why?
Databases as Topic
1
2009
37
0.020
Why?
Parathyroid Hormone
1
2010
147
0.020
Why?
Lymphocytes
1
2010
152
0.020
Why?
Cytoskeleton
1
2008
39
0.020
Why?
Genotype
1
2009
537
0.020
Why?
Twins
1
2007
33
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Cytological Techniques
1
2007
14
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
225
0.020
Why?
NF-kappa B p50 Subunit
1
2007
17
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Karyotyping
1
2007
83
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
65
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
Antigen Presentation
1
2007
25
0.020
Why?
Benzamides
1
2007
51
0.020
Why?
Remission Induction
1
2007
207
0.020
Why?
Polysaccharide-Lyases
1
2007
6
0.020
Why?
Leukocytes, Mononuclear
1
2007
116
0.020
Why?
Plasmids
1
2007
161
0.020
Why?
Tissue Culture Techniques
1
2007
40
0.020
Why?
Interferon-gamma
1
2007
177
0.020
Why?
Enzyme Activation
1
2007
276
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
244
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Anticoagulants
1
2009
250
0.020
Why?
Piperazines
1
2007
117
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
47
0.020
Why?
Neoplasms, Experimental
1
2007
114
0.020
Why?
Dendritic Cells
1
2007
133
0.020
Why?
Diagnosis, Differential
1
2010
1037
0.020
Why?
Incidence
1
2009
1003
0.020
Why?
Receptors, Estrogen
1
2007
130
0.020
Why?
Polymerase Chain Reaction
1
2007
453
0.020
Why?
Chromosomes, Human
1
2006
41
0.020
Why?
Gelatinases
1
2006
32
0.020
Why?
Rabbits
1
2006
370
0.020
Why?
Endopeptidases
1
2006
66
0.020
Why?
Coculture Techniques
1
2006
146
0.020
Why?
Combined Modality Therapy
1
2007
637
0.020
Why?
Cyclin D3
1
2005
5
0.020
Why?
Cyclin D2
1
2005
20
0.020
Why?
Trisomy
1
2005
31
0.020
Why?
Adipocytes
1
2006
121
0.020
Why?
Oligonucleotide Probes
1
2004
20
0.020
Why?
Stem Cells
1
2006
171
0.020
Why?
Epithelium
1
2004
65
0.020
Why?
Molecular Sequence Data
1
2006
792
0.020
Why?
Endothelium, Vascular
1
2006
252
0.010
Why?
Ovary
1
2004
104
0.010
Why?
Endothelial Cells
1
2006
269
0.010
Why?
Databases, Factual
1
2007
658
0.010
Why?
Bacterial Proteins
1
2007
376
0.010
Why?
RNA, Complementary
1
2003
3
0.010
Why?
Autocrine Communication
1
2003
8
0.010
Why?
Paracrine Communication
1
2003
12
0.010
Why?
Metaphase
1
2003
44
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Cell Separation
1
2003
89
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
NAD+ Nucleosidase
1
2002
3
0.010
Why?
Biopsy
1
2005
584
0.010
Why?
Cell Communication
1
2003
69
0.010
Why?
Antigens, Differentiation
1
2002
17
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
138
0.010
Why?
Cohort Studies
1
2006
1422
0.010
Why?
Immunoglobulins
1
2002
79
0.010
Why?
Database Management Systems
1
2002
28
0.010
Why?
Reproducibility of Results
1
2005
1193
0.010
Why?
Logistic Models
1
2003
888
0.010
Why?
Magnetic Resonance Imaging
1
2003
1537
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description